Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Burden of pricey hepatitis C drugs heaviest in eastern Europe

New hepatitis C drugs that can cure the liver-destroying disease are revolutionizing treatment but their high price is a huge burden in some countries, particularly in central and eastern Europe, according to a new study.

Published
01 June 2016
From
Reuters
Large global range of prices for hepatitis C medicines raises concerns about affordability

The prices and affordability of recently developed and highly effective direct-acting antivirals for treating hepatitis C vary greatly among countries worldwide, according to a study published this week in PLOS Medicine.

Published
01 June 2016
From
Eurekalert Inf Dis
Study Finds Patients with Hepatitis C Have Higher Hospitalization Rate

A study that explored the healthcare burden of chronic infection of the hepatitis C virus found that patients with the disease were more than 3 times likely to be hospitalized than patients in a comparison group.

Published
31 May 2016
From
MD Magazine
Washington Ordered to Cover Hepatitis C Drugs During Lawsuit

Washington’s Medicaid program must pay for expensive hepatitis C treatments like Gilead Sciences Inc.’s Harvoni ahead of a trial to determine whether the state can exclude the medicine from being covered.

Published
31 May 2016
From
Bloomberg
Philippines FDA warns against fake Hepatitis C medicines

The Philippines' Food and Drug Administration (FDA) has warned against a fake Hepatitis C medicines circulating in Southeast Asia.

Published
31 May 2016
From
GMA News
Merck Receives Positive CHMP Opinion for ZEPATIER™ (elbasvir and grazoprevir) in the European Union

Merck (NYSE:MRK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of ZEPATIER™ (elbasvir and grazoprevir), an investigational, once-daily, fixed-dose combination tablet for the treatment of chronic hepatitis C virus (HCV) in adult patients.

Published
30 May 2016
From
MSD press release
European CHMP Adopts Positive Opinion for Gilead’s Epclusa® (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C

Epclusa is Gilead’s Third Sofosbuvir-Based Treatment to Receive a CHMP Positive Opinion for the Treatment of Chronic HCV Infection.

Published
27 May 2016
From
Gilled press relase
WHA69: Leave no one behind, World Hepatitis Alliance

Raquel Peck is the CEO of the World Hepatitis Alliance (WHA), she shares her hope that stronger action on viral hepatitis will be high on the agenda for the 69th World Health Assembly in Geneva (convening this week).

Published
25 May 2016
From
PLoS Blogs (blog)
Only treating patients with cirrhosis with DAAs will have limited impact on HCV epidemic in England

Targeting new hepatitis C virus (HCV) direct-acting antivirals (DAAs) at patients with cirrhosis will substantially reduce short-term incidence of end-stage liver disease (ESLD) and liver cancer (HCC) in

Published
25 May 2016
By
Michael Carter
Primrose Healthcare Launches an Innovative Alcohol App to Help Hepatitis C Patients Overcome Alcohol Addiction

Leveraging mobile technology and powered by Here and Now Systems, the alcohol app provides personalized education and resources through goal setting, alerts, coaching, and ongoing feedback to better engage and support hepatitis C patients on their journey toward alcohol addiction recovery.

Published
24 May 2016
From
Business Wire (press release)

Filter by country